Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessment of Foetal DNA in Maternal Blood – A Useful Tool in the Hands of Prenatal Specialists

12 Dec 2012

Abstract excerpt

Over the last few years, first trimester screening between 11+ and 13+ weeks of gestation has become one of the most important ultrasound examinations in pregnancy, as it allows physicians to predict several pregnancy complications including pre-eclampsia or pre-term birth. Screening for trisomies 21/18 and 13 using maternal and gestational age, foetal nuchal translucency, and maternal serum biochemistry was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fetal and Pediatric Neurological Disorders
Share to Prenatal Screening and Diagnostics

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 25258455
DOI: 10.1055/s-0032-1327960

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessment of Foetal DNA in Maternal Blood – A Useful Tool in the Hands of Prenatal SpecialistsPMID 25258455Read ↗

Non-Invasive Prenatal Testing: Current Perspectives and Future ChallengesSemantic proximity Read ↗

Clinical Perspective of Cell-Free DNA Testing for Fetal AneuploidiesSemantic proximity Read ↗

Non-Invasive Prenatal Screening from a Genetic Counseling Prospective: Pre and Post-Genetic Counseling Regarding Rare Chromosomal Abnormalities and Incidental FindingSemantic proximity Read ↗

Quality Requirements for the early Fetal Ultrasound Assessment at 11–13+6 Weeks of Gestation (DEGUM Levels II and III)Semantic proximity Read ↗

Is there still a role for nuchal translucency measurement in the changing paradigm of first trimester screening?Semantic proximity Read ↗

[New frontiers in noninvasive, prenatal screening and diagnosis: fetal DNA circulating in maternal blood].Semantic proximity Read ↗

Cell-Free Fetal DNA and Non-Invasive Prenatal Diagnosis of Chromosomopathies and Pediatric Monogenic Diseases: A Critical Appraisal and Medicolegal RemarksSemantic proximity Read ↗

Reappraisal of evolving methods in non-invasive prenatal screening: Discovery, biology and clinical utilitySemantic proximity Read ↗

Noninvasive Prenatal Testing - When Is It Advantageous to ApplySemantic proximity Read ↗

Cell‐free <scp>DNA</scp> testing of maternal blood in screening for trisomies in twin pregnancy: updated cohort study at 10–14 weeks and meta‐analysisSemantic proximity Read ↗

Clinical applications of maternal plasma fetal DNA analysis: translating the fruits of 15 years of researchSemantic proximity Read ↗

Overall evaluation of the clinical value of prenatal screening for fetal-free DNA in maternal bloodSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.